Expertise in
7
conditions

Dr. Robin Eisner

Oncology
Chi Health Clinic Women's Health (CuMc-Bergan Mercy)
7710 Mercy Rd Ste 1000, 
Omaha, NE 
Expertise in
7
conditions
Chi Health Clinic Women's Health (CuMc-Bergan Mercy)
7710 Mercy Rd Ste 1000, 
Omaha, NE 

Overview

Robin Eisner is an Oncologist in Omaha, Nebraska. Dr. Eisner is highly rated in 7 conditions, according to our data. His top areas of expertise are Ovarian Cancer, Ovarian Carcinosarcoma, Virilizing Ovarian Tumor, and Sertoli-Leydig Cell Tumor.

His clinical research consists of co-authoring 30 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Oncology

Licenses

Obstetrics & Gynecology in NE

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

Chi Health Clinic Women's Health (CuMc-Bergan Mercy)
7710 Mercy Rd Ste 1000, Omaha, NE 68124
Other Locations
CHI Health Partners
7261 Mercy Rd, Omaha, NE 68124

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Comparative Analysis of CA-IX, p16, Proliferative Markers, and Human Papilloma Virus (HPV) in the Diagnosis of Significant Cervical Lesions in Patients With a Cytologic Diagnosis of Atypical Glandular Cells (AGC)
Comparative Analysis of CA-IX, p16, Proliferative Markers, and Human Papilloma Virus (HPV) in the Diagnosis of Significant Cervical Lesions in Patients With a Cytologic Diagnosis of Atypical Glandular Cells (AGC)
Enrollment Status: Active_not_recruiting
Publish Date: May 03, 2024
Intervention Type: Other
Study Phase: Not Applicable
A Single Arm, Multicenter, International Trial of Tisotumab Vedotin (HuMax®-TF-ADC) in Previously Treated, Recurrent or Metastatic Cervical Cancer
A Single Arm, Multicenter, International Trial of Tisotumab Vedotin (HuMax®-TF-ADC) in Previously Treated, Recurrent or Metastatic Cervical Cancer
Enrollment Status: Completed
Publish Date: July 25, 2023
Intervention Type: Drug
Study Drug: Tisotumab Vedotin
Study Phase: Phase 2
FORWARD I: A Randomized, Open Label Phase 3 Study to Evaluate the Safety and Efficacy of Mirvetuximab Soravtansine (IMGN853) Versus Investigator's Choice of Chemotherapy in Women With Folate Receptor Alpha Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer
FORWARD I: A Randomized, Open Label Phase 3 Study to Evaluate the Safety and Efficacy of Mirvetuximab Soravtansine (IMGN853) Versus Investigator's Choice of Chemotherapy in Women With Folate Receptor Alpha Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer
Enrollment Status: Completed
Publish Date: October 14, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

30 Total Publications

Retraction Note: A83-01 inhibits TGF-β-induced upregulation of Wnt3 and epithelial to mesenchymal transition in HER2-overexpressing breast cancer cells.
Retraction Note: A83-01 inhibits TGF-β-induced upregulation of Wnt3 and epithelial to mesenchymal transition in HER2-overexpressing breast cancer cells.
Journal: Breast cancer research and treatment
Published: May 10, 2024
Similar Doctors
Expertise in
42
conditions
Dr. Nicole Shonka
Oncology
Expertise in
42
conditions
Dr. Nicole Shonka
Oncology

Fred & Pamela Buffett Cancer Center-Nebraska Medical Center

505 S 45th St, 
Omaha, NE 
 (1320.6 miles away)
402-559-5600
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Nicole Shonka is an Oncologist in Omaha, Nebraska. Dr. Shonka is highly rated in 42 conditions, according to our data. Her top areas of expertise are Glioma, Astrocytoma, Glioblastoma, and Brain Tumor.

Expertise in
17
conditions
Dr. Luke Nordquist
Oncology
Expertise in
17
conditions
Dr. Luke Nordquist
Oncology

The Urology Cancer Center

17607 Gold Plz, 
Omaha, NE 
 (1309.7 miles away)
402-991-8468
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Luke Nordquist is an Oncologist in Omaha, Nebraska. Dr. Nordquist is highly rated in 17 conditions, according to our data. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, and Prostatectomy.

Expertise in
25
conditions
Dr. Robert Bociek
Oncology
Expertise in
25
conditions
Dr. Robert Bociek
Oncology

Fred & Pamela Buffett Cancer Center-Nebraska Medical Center

505 S 45th St, 
Omaha, NE 
 (1320.6 miles away)
402-559-5600
Languages Spoken:
English
See accepted insurances

Robert Bociek is an Oncologist in Omaha, Nebraska. Dr. Bociek is highly rated in 25 conditions, according to our data. His top areas of expertise are Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Mantle Cell Lymphoma (MCL), Bone Marrow Transplant, and Bone Marrow Aspiration.

Frequently Asked Questions about Dr. Robin Eisner

How do I make an appointment with Dr. Robin Eisner?

You can book an appointment with Dr. Robin Eisner by calling their office at 402-717-3010. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Robin Eisner a top-rated expert for Ovarian Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Robin Eisner is classified as an Advanced expert for Ovarian Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Robin Eisner specialize in?

While Dr. Robin Eisner is a Oncology, they have specific expertise in Ovarian Cancer, Ovarian Carcinosarcoma, and Virilizing Ovarian Tumor. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Robin Eisner participate in research or clinical trials?

Yes. Dr. Robin Eisner has published 30 articles and abstracts on conditions like Ovarian Cancer. You can view a list of Dr. Robin Eisner's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Robin Eisner accept my insurance?

Dr. Robin Eisner accepts most major insurance plans, including Blue Cross Blue Shield and Blue Shield of California. We recommend calling the office directly at 402-717-3010 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Eisner's expertise for a condition
ConditionClose
      View All 7 Advanced Conditions
      View All 12 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile